hotspot -WSS

hotspot

author：Wikipedia 2025-10-01 15:31:03 - browse：2

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： How to fix the rural physician shortage in the U.S.

entertainment

WSS

How to fix the rural physician shortage in the U.S.

Biotech companies concerned about China biosecurity crackdown

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

The high cost of giving birth even with insurance

Supreme Court strikes down use of affirmative action

In search for therapies for solid tumors, companies turn to claudin

entertainment

hotspot

explore

Continuity nursing helped my family in our darkest PICU moments

Biotech companies concerned about China biosecurity crackdown

Novavax promises a turnaround & Lilly roils the obesity market

Malaria cases in Florida and Texas: Here’s what you need to know

Jerome Adams on the need for new antivirals for Covid

Medical device lobby: We're tired of waiting on Medicare coverage

Virginia high school admissions case could be legal follow

RaDonda Vaught to speak at CommonSpirit event on patient safety

How to save PrEP access — and even expand it

Why getting cancer drugs just got harder for rural patients

hotspot

Continuity nursing helped my family in our darkest PICU moments

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

How to address the problem of discarded donor organs

United colonoscopy coverage change 'may cost lives,' doctors say

As demand for Covid shots wanes, Moderna seeks its next success

Flu vaccine offering decent levels of protection this winter, new data show

Wikipedia

focus

entertainment

leisure time